| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.21 | 9e-07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.19 | 5e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-06 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.18 | 9e-06 |